Aiming to Push Genomics Forward in New Study

January 13, 2014 2:45 PM

13 0

Aiming to Push Genomics Forward in New Study

Pharmaceutical companies invested heavily in genetic studies in the frenzy after the sequencing of the human genome a decade ago, only to find it did not lead to the expected bonanza of new drugs.

Now, however, Regeneron Pharmaceuticals, a fast-growing biotechnology company, is undertaking an ambitious new genomics effort, in partnership with the Geisinger Health System, which treats three million people in Pennsylvania.

Read more

To category page

Loading...